The role of UGT1A1 promoter polymorphism and exon-1 mutations in neonatal jaundice

References

• Madan A, McMahon JR, Stevenson DK, Neonatal hyperbilirubinemia. In: Taeusch HW, Ballard RA, Gleason CA, eds. Avery’s disease of the newborn. Philadelphia (PA): WB Saunders; 2005:1226–56.
   Google Scholar
• Maruo Y, Nishizawa K, Sato H, et al. Association of neonatal hyperbilirubinemia with bilirubin UDP-glucuronosyltransferase polymorphism. Pediatrics 1999;103:1224–7.
   PubMed Web of Science ®Google Scholar
• Sarici SU, Saldir M. Genetic factors in neonatal hyperbilirubinemia and kernicterus. Turk J Pediatr 2007;49:245–9.
   PubMed Web of Science ®Google Scholar
• Brown AK, Zuelzer WW, Burnett HH. Studies on the neonatal development of the glucuronide conjugating system. J Clin Invest 1958;37:332–40.
   PubMed Web of Science ®Google Scholar
• Yusoff S, van Rostenberghe H, Yusoff NM, et al. Frequencies of A(TA)7TAA, G71R, and G493R mutations of the UGT1A1 gene in the Malaysian population. Biol Neonate 2006;89:171–6.
   PubMedGoogle Scholar
• Seidman DS, Ergaz Z, Paz I, et al. Predicting the risk of jaundice in fullterm healthy newborns: a prospective population based study. J Perinatol 1999;19:564–7.
   PubMedGoogle Scholar
• Kaplan M, Hammerman C, Maisels MJ. Bilirubin genetics for the nongeneticist: hereditary defects of neonatal bilirubin conjugation. Pediatrics 2003;111:886–93.
   PubMed Web of Science ®Google Scholar
• Sarici SU, Yurdakok M, Serdar MA, et al. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility. Pediatrics 2002;109:e53.
   PubMed Web of Science ®Google Scholar
• Alpay F, Sarıcı SU, Tosuncuk HD, et al. The value of first-day bilirubin measurement in predicting the development of significant hyperbilirubinemia in healthy term newborns. Pediatrics 2000;106:E16.
   PubMed Web of Science ®Google Scholar
• Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999;103:6–14.
   PubMed Web of Science ®Google Scholar
• Kaplan M, Hammerman C, Renbaum P, et al. Gilbert’s syndrome and hyperbilirubinaemia in ABO-incompatible neonates. Lancet 2000;356:652–3.
   PubMed Web of Science ®Google Scholar
• Babaoglu MO, Yigit S, Aynacioglu AS, et al. Neonatal jaundice and bilirubin UDP-glucuronosyl transferase 1A1 gene polymorphism in Turkish patients. Basic Clin Pharmacol Toxicol 2006;98:377–80.
   PubMed Web of Science ®Google Scholar
• Maisels MJ, Gifford K. Normal serum bilirubin levels in the newborn and the effect of breast-feeding. Pediatrics 1986;78:837–43.
   PubMed Web of Science ®Google Scholar
• Ulgenalp A, Duman N, Schaefer FV, et al. Analyses of polymorphism for UGT1*1 Exon 1 promoter in neonates with pathologic and prolonged jaundice. Biol Neonate 2003;83:258–62.
   PubMedGoogle Scholar
• Herschel M, Karrison T, Wen M, et al. Isoimmunization is unlikely to be the cause of hemolysis in ABO-incompatible but direct antiglobulin test-negative neonates. Pediatrics 2002;110:127–30.
   PubMed Web of Science ®Google Scholar
• Huang CS, Chang PF, Huang MJ, et al. Relationship between bilirubin UDP-glucuronosyl transferase 1A1 gene and neonatal hyperbilirubinemia. Pediatr Res 2002;52:601–5.
   PubMed Web of Science ®Google Scholar
• Bancroft JD, Kreamer B, Gourley GR. Gilbert syndrome accelerates development of neonatal jaundice. J Pediatr 1998;132:656–60.
   PubMed Web of Science ®Google Scholar
• Monaghan G, McLellan A, McGeehan A, et al. Gilbert’s syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn. J Pediatr 1999;134:441–6.
   PubMed Web of Science ®Google Scholar
• Akaba K, Kimura T, Sasaki A, et al. Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese. J Hum Genet 1999;44:22–5.
   PubMed Web of Science ®Google Scholar
• Kaplan M, Hammerman C. Bilirubin and the genome: the hereditary basis of unconjugated neonatal hyperbilirubinemia. Curr Pharmacogenom 2005;3:21–42.
   Google Scholar
• Kaplan M, Renbaum P, Levy-Lahad E, et al. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci USA 1997;94:12128–32.
   PubMed Web of Science ®Google Scholar
• Ergin H, Bican M, Atalay OE. A causal relationship between UDP-glucuronosyltransferase 1A1 promoter polymorphism and idiopathic hyperbilirubinemia in Turkish newborns. Turk J Pediatr 2010;52:28–34.
   PubMed Web of Science ®Google Scholar
• Kiliç I, Cakaloz I, Atalay E. Frequency of UDP-glucuronosyltransferase 1 (UGT1A1) gene promoter polymorphisms in neonates with prolonged and pathological jaundice in the Denizli region of Turkey. Int J Clin Pharmacol Ther 2007;45:475–6.
   PubMed Web of Science ®Google Scholar
• Muslu N, Turhan AB, Eskandari G, et al. The frequency of UDP-glucuronosyltransferase 1A1 promoter region (TA)7 polymorphism in newborns and it’s relation with jaundice. J Trop Pediatr 2007;53:64–8.
   PubMed Web of Science ®Google Scholar
• Travan L, Lega S, Crovella S, et al. Severe neonatal hyperbilirubinemia and UGT1A1 promoter polymorphism. J Pediatr 2014;165:42–5.
   PubMed Web of Science ®Google Scholar
• Žaja O, Tiljak MK, Štefanović M, et al. Correlation of UGT1A1 TATA-box polymorphism and jaundice in breastfed newborns – early presentation of Gilbert’s syndrome. J Matern Fetal Neonatal Med 2014;27:844–50.
   PubMed Web of Science ®Google Scholar
• Kaveh M, Esmailnia T, Nayeri F, et al. UDP-glucuronosyltransferase promoter polymorphism in Iranian neonates with idiopathic hyperbilirubinemia. Acta Med Iran 2013;51:789–92.
   PubMedGoogle Scholar
• Kiliç I, Koseler A, Cakaloz I, et al. Screening for G71R mutation of the UDP-glucuronosyltransferase 1 (UGT1A1) gene in neonates with pathologic and prolonged hyperbilirubinemia in Turkey. Int J Clin Pharmacol Ther 2010;48:504–8.
   PubMed Web of Science ®Google Scholar
• Narter F, Can G, Ergen A, et al. Neonatal hyperbilirubinemia and G71R mutation of the UGT1A1 gene in Turkih patients. J Matern Fetal Neonatal Med 2011;24:313–6.
   PubMed Web of Science ®Google Scholar
• Bosma PJ, Chowdhury JR, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert’s syndrome. N Engl J Med 1995;333:1171–5.
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Soeda Y, Kamisako T, et al. Analysis of bilirubin uridine 5’-diphophate (UDP)-glucuronosyl-transferase gene mutations in seven patients with Cricler-Najjar syndrome type II. J Hum Genet 1998;43:111–4.
   PubMed Web of Science ®Google Scholar
• Takeuchi K, Kobayashi Y, Tamaki S, et al. Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert’s syndrome as well as in healthy Japanese subjects. J Gastroenterol Hepatol 2004;19:1023–8.
   PubMed Web of Science ®Google Scholar
• Zhou YY, Lee LY, Ng SY, et al. UGT1A1 haplotype mutation among Asians in Singapore. Neonatology 2009;96:150–5.
   PubMed Web of Science ®Google Scholar
• Radu P, Atsmon J. Gilbert’s syndrome – clinical and pharmacological implications. Isr Med Assoc J 2001;3:593–8.
   PubMed Web of Science ®Google Scholar